CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 86 filers reported holding CRINETICS PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $192,626 | +168.1% | 6,477 | +62.5% | 0.01% | +166.7% |
Q2 2023 | $71,846 | +12.2% | 3,987 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $64,031 | -19.3% | 3,987 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $79,341 | +1.7% | 3,987 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $78,000 | +5.4% | 3,987 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $74,000 | -5.1% | 3,987 | +11.9% | 0.00% | 0.0% |
Q1 2022 | $78,000 | -22.8% | 3,562 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $101,000 | +68.3% | 3,562 | +24.5% | 0.00% | +50.0% |
Q3 2021 | $60,000 | +11.1% | 2,860 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $54,000 | +45.9% | 2,860 | +19.7% | 0.00% | +100.0% |
Q1 2021 | $37,000 | +8.8% | 2,390 | 0.0% | 0.00% | -50.0% |
Q4 2020 | $34,000 | -8.1% | 2,390 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $37,000 | -11.9% | 2,390 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $42,000 | +200.0% | 2,390 | +151.1% | 0.00% | +100.0% |
Q1 2020 | $14,000 | -41.7% | 952 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $24,000 | +71.4% | 952 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $14,000 | -41.7% | 952 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $24,000 | +84.6% | 952 | +65.9% | 0.00% | 0.0% |
Q1 2019 | $13,000 | -23.5% | 574 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $17,000 | +6.2% | 574 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $16,000 | – | 574 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Saturn V Capital Management LP | 623,819 | $11,336,501 | 9.41% |
Finepoint Capital LP | 822,745 | $15,056 | 4.87% |
Bain Capital Life Sciences Investors, LLC | 2,305,558 | $42,192 | 4.72% |
Opaleye Management Inc. | 732,000 | $13,395,600 | 4.66% |
5AM Venture Management, LLC | 862,286 | $15,779,834 | 4.24% |
SPHERA FUNDS MANAGEMENT LTD. | 671,644 | $12,291,085 | 2.64% |
First Light Asset Management, LLC | 1,329,313 | $24,326,428 | 2.26% |
BRAIDWELL LP | 3,469,674 | $63,495,034 | 2.13% |
BVF INC/IL | 2,736,613 | $50,080,018 | 2.11% |
Perceptive Advisors | 4,039,276 | $73,918,751 | 2.08% |